Suchergebnisse
On Holding (ONON) Falls More Steeply Than Broader Market: What Investors Need to Know
In the latest close session, On Holding (ONON) was down 1.4% at $36.73. The stock's performance was behind the S&P 500's daily loss of 0.64%. On the other hand, the Dow registered a loss of 0.59%
Okta (OKTA) Increases Despite Market Slip: Here's What You Need to Know
Okta (OKTA) closed at $77.64 in the latest trading session, marking a +2.48% move from the prior day. The stock outperformed the S&P 500, which registered a daily loss of 0.64%. Elsewhere, the Dow
Duke Energy (DUK) Sees a More Significant Dip Than Broader Market: Some Facts to Know
In the latest trading session, Duke Energy (DUK) closed at $125.67, marking a -1.71% move from the previous day. The stock trailed the S&P 500, which registered a daily loss of 0.64%. Elsewhere, the
Louisiana-Pacific (LPX) Declines More Than Market: Some Information for Investors
Louisiana-Pacific (LPX) ended the recent trading session at $70.71, demonstrating a -4.06% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily loss
Amkor Technology (AMKR) Advances While Market Declines: Some Information for Investors
Amkor Technology (AMKR) closed the most recent trading day at $70.21, moving +1.11% from the previous trading session. The stock outperformed the S&P 500, which registered a daily loss of 0.64%
Builders FirstSource (BLDR) Dips More Than Broader Market: What You Should Know
Builders FirstSource (BLDR) closed at $89.76 in the latest trading session, marking a -1.71% move from the prior day. The stock trailed the S&P 500, which registered a daily loss of 0.64%. On the
Here's Why Grab Holdings Limited (GRAB) Fell More Than Broader Market
Grab Holdings Limited (GRAB) ended the recent trading session at $4.08, demonstrating a -3.09% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily
Here's Why AngloGold Ashanti (AU) Fell More Than Broader Market
AngloGold Ashanti (AU) ended the recent trading session at $100.45, demonstrating a -5.67% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily loss
ATI (ATI) Sees a More Significant Dip Than Broader Market: Some Facts to Know
In the latest close session, ATI (ATI) was down 3.11% at $158.95. The stock's change was less than the S&P 500's daily loss of 0.64%. On the other hand, the Dow registered a loss of 0.59%, and the
Cardinal Health (CAH) Registers a Bigger Fall Than the Market: Important Facts to Note
In the latest close session, Cardinal Health (CAH) was down 2.96% at $204.92. The stock's change was less than the S&P 500's daily loss of 0.64%. At the same time, the Dow lost 0.59%, and the
Howmet (HWM) Declines More Than Market: Some Information for Investors
Howmet (HWM) closed at $247.72 in the latest trading session, marking a -3.09% move from the prior day. This move lagged the S&P 500's daily loss of 0.64%. On the other hand, the Dow registered a
UBS Aktie: Kurskorrektur in Sicht?
Der Schweizer Bundesrat stellt die Weichen für die UBS. Ein neues Regulierungspaket droht die…
Der Beitrag UBS Aktie: Kurskorrektur in Sicht? erschien zuerst auf kapitalmarktexperten.de.
Quelle kapi
3 Top-Ranked Healthcare Mutual Funds to Strengthen Your Portfolio
One of the best ways to safeguard investments is by parking money in the healthcare sector. This is because demand for healthcare services remains relatively stable, regardless of market conditions
Nahost-Krieg lähmt Weltwirtschaft
Der Krieg im Nahen Osten hat sich längst vom regionalen Konflikt zur globalen Wirtschaftsstörung…
Der Beitrag Nahost-Krieg lähmt Weltwirtschaft erschien zuerst auf kapitalmarktexperten.de.
Quelle ka
Gildan Activewear's Q1 Earnings on the Horizon: Factors to Note
Gildan Activewear Inc. GIL is scheduled to report first-quarter 2026 results on April 30, before the opening bell, and is expected to have registered top-line growth. The Zacks Consensus Estimate
Ocugen Stock Outlook: Valuation, Cash Runway and Dilution Risk
Ocugen OCGN is advancing a late-stage ophthalmology pipeline built around one-time gene therapies for retinal diseases with large unmet needs. Multiple clinical readouts and regulatory milestones
MRK Down as Triplet Therapy Fails to Meet Goal in Kidney Cancer Study
Merck MRK, along with its partner Eisai, announced that the phase III LITESPARK-012 study, which evaluated Keytruda-based triplet regimens for the first-line treatment of patients with advanced
Zoom Communications (ZM) Rises Higher Than Market: Key Facts
In the latest trading session, Zoom Communications (ZM) closed at $91.92, marking a +1.06% move from the previous day. The stock exceeded the S&P 500, which registered a gain of 1.05% for the day
Fortinet (FTNT) Outperforms Broader Market: What You Need to Know
In the latest close session, Fortinet (FTNT) was up +2.15% at $87.09. The stock exceeded the S&P 500, which registered a gain of 1.05% for the day. Meanwhile, the Dow gained 0.69%, and the Nasdaq, a
Clear Secure (YOU) Stock Declines While Market Improves: Some Information for Investors
In the latest close session, Clear Secure (YOU) was down 2.4% at $56.99. The stock's change was less than the S&P 500's daily gain of 1.05%. On the other hand, the Dow registered a gain of 0.69%



